1. Home
  2. SBCF vs TXG Comparison

SBCF vs TXG Comparison

Compare SBCF & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SBCF

Seacoast Banking Corporation of Florida

N/A

Current Price

$34.89

Market Cap

3.2B

Sector

Finance

ML Signal

N/A

Logo 10x Genomics Inc.

TXG

10x Genomics Inc.

N/A

Current Price

$18.54

Market Cap

2.8B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SBCF
TXG
Founded
1926
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SBCF
TXG
Price
$34.89
$18.54
Analyst Decision
Buy
Hold
Analyst Count
2
14
Target Price
$32.00
$16.18
AVG Volume (30 Days)
756.5K
2.7M
Earning Date
01-29-2026
02-12-2026
Dividend Yield
2.19%
N/A
EPS Growth
10.56
N/A
EPS
1.57
N/A
Revenue
$601,366,000.00
$641,814,000.00
Revenue This Year
$43.51
$4.94
Revenue Next Year
$5.52
N/A
P/E Ratio
$22.05
N/A
Revenue Growth
20.48
1.92
52 Week Low
$21.36
$6.78
52 Week High
$35.46
$23.56

Technical Indicators

Market Signals
Indicator
SBCF
TXG
Relative Strength Index (RSI) 63.35 38.96
Support Level $34.29 $17.37
Resistance Level $35.24 $20.49
Average True Range (ATR) 0.92 1.18
MACD 0.07 -0.60
Stochastic Oscillator 79.92 8.89

Price Performance

Historical Comparison
SBCF
TXG

About SBCF Seacoast Banking Corporation of Florida

Seacoast Banking Corp of Florida is a holding company for Seacoast National Bank. The company provides integrated financial services including commercial and consumer banking, wealth management, and mortgage and insurance services to customers across Florida, and through mobile and online banking solutions. In addition, it provides services such as treasury management, brokerage and credit facilities.

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

Share on Social Networks: